Stock comparison
Alvotech
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ALVO
Alvotech
Market cap
$1.04B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ALVO | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 44D | 77B | LMAT |
| Benjamin Graham | 51D | 89A | LMAT |
| Philip Fisher | 55C | 81C | LMAT |
| Peter Lynch | 78C | 67B | ALVO |
| Joel Greenblatt | 45D | 56D | LMAT |
| Charlie Munger | 52D | 68D | LMAT |
| Terry Smith | 43D | 69D | LMAT |
Side-by-side metrics
| Metric | ALVO | LMAT |
|---|---|---|
| Market cap | $1.04B | $2.23B |
| P/E (TTM) | 33.1x | 37.1x |
| EV/EBIT | 29.5x | 36.6x |
| ROIC (TTM) | 1.3% | 9.43% |
| Gross margin | 59.82% | 72.39% |
| Net margin | 4.76% | 24.35% |
| Revenue CAGR 5y | 99.83% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | - | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALVO leads on
- Debt / Equity-vs 0.5x+109%
- Revenue CAGR 5y99.83%vs 12.75%+87%
- EV/EBIT29.5xvs 36.6x+19%
- P/E (TTM)33.1xvs 37.1x+11%
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- ROIC (TTM)9.43%vs 1.3%+86%
- Net margin24.35%vs 4.76%+80%
- Market cap$2.23Bvs $1.04B+53%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.